Quick Answer
Kura Oncology, Inc. reported Shares Outstanding of 87.86 million shares for fiscal year 2025.
Kura Oncology, Inc. Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2025 | 87.86M | +12.3% |
| 2024 | 78.23M | +5.2% |
| 2023 | 74.35M | +8.8% |
| 2022 | 68.31M | +2.6% |
| 2021 | 66.57M | +0.6% |
| 2020 | 66.19M | +45.9% |
| 2019 | 45.38M | +19.0% |
| 2018 | 38.15M | +29.6% |
| 2017 | 29.42M | +52.1% |
| 2016 | 19.35M | +6.7% |
| 2015 | 18.14M | +4313.1% |
| 2014 | 411,000 | -91.8% |
| 2013 | 5.00M | +0.0% |
| 2012 | 5.00M | +0.0% |
| 2011 | 5.00M | +0.0% |
| 2010 | 5.00M | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | 87.02M | +11.9% | +0.3% |
| June 30, 2025 | 86.80M | +13.6% | +7.5% |
| March 31, 2025 | 80.78M | +6.0% | +3.3% |
| December 31, 2024 | 78.23M | +5.2% | +0.6% |
| September 30, 2024 | 77.75M | +4.7% | +1.7% |
| June 30, 2024 | 76.42M | +3.1% | +0.3% |
| March 31, 2024 | 76.18M | +11.3% | +2.5% |
| December 31, 2023 | 74.35M | +8.8% | +0.1% |
- Kura Oncology, Inc. showed an increase of +12.3% in Shares Outstanding compared to the prior fiscal year.
- Over the 2010–2025 period, Kura Oncology, Inc.’s shares outstanding has grown by 1657.1% (from 5.00 million shares to 87.86 million shares).
- The most recent figure is from Kura Oncology, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 5, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: